Veterinary medicines European public assessment report (EPAR): Suiseng Diff/A, clostridioides difficile,clostridium perfringens vaccine, inactivated, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Stelfonta, tigilanol tiglate, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Sevohale (previously Sevocalm), sevoflurane, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Sedadex, dexmedetomidine, Status: Authorised

EMEA-002338-PIP01-18

PSUSA/00002698/202501

Human medicines European public assessment report (EPAR): Orserdu, elacestrant, Date of authorisation: 15/09/2023, Revision: 4, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Rabitec, rabies vaccine (live, oral) for foxes and raccoon dogs, Status: Authorised

Opinion/decision on a Paediatric investigation plan (PIP): Isturisa, osilodrostat, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Endocrine disorders, PIP number: P/0325/2024

Human medicines European public assessment report (EPAR): Bortezomib Sun, bortezomib, Date of authorisation: 22/07/2016, Revision: 15, Status: Authorised